Sanofi’s hemophilia A data set stage for regulatory filings, matchup with Roche

Sanofi is already a player in the hemophilia A market, but the company is developing another therapy that could better match up against a blockbuster product from rival Roche. The experimental Sanofi therapy has posted encouraging preliminary data in a pivotal study, and the pharmaceutical…